Skip to main content
Clinical Trials/NCT05231200
NCT05231200
Recruiting
Not Applicable

Alberta (AB) Collaborative Quality Improvement Strategies to Improve Outcomes of Preterm Infants 32 - 36 Weeks' Gestation: A Stepped-Wedge Cluster Randomized Trial

University of Calgary12 sites in 1 country9,500 target enrollmentMay 1, 2023
ConditionsLength of Stay

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Length of Stay
Sponsor
University of Calgary
Enrollment
9500
Locations
12
Primary Endpoint
Length of Stay
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

The ABC-QI Trial aims to implement collaborative quality improvement (QI) strategies to standardize care for 32-36 week infants in Level 2 and 3 Neonatal intensive care units (NICUs) across the province of Alberta. The investigators want to know if using validated quality improvement methods and evidence-based care bundles will decrease the duration of hospital stay and get babies home as quickly as possible.

Detailed Description

A stepped-wedge cluster randomized trial will be conducted in 12 NICUs across Alberta (10 Level II and 2 Level III). Each NICU is considered a cluster and will be randomized to transition to the intervention arm at one of three time points. The planned trial interventions include: Intervention arm (Collaborative QI Strategies): The study intervention is a constellation of collaborative QI strategies: 1) QI Team Building; 2) QI Education; 3) Implementation of 2 standardized practice care bundles (Respiratory Care, and Nutritional Care); 4) QI mentoring; and 5) Collaborative networking. Based on the randomization, 4 NICUs will transition to the intervention arm at the end of each year. Control arm (current management): All participating NICUs will be in the control arm during the first year prior to randomization to create a baseline of the current practices and between-units variation. NICUs in the control arm can continue conducting QI activities relevant to current practice, but without receiving the interventions outlined above.

Registry
clinicaltrials.gov
Start Date
May 1, 2023
End Date
August 30, 2027
Last Updated
9 months ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Preterm Infants: Infants born at 32 to 36 weeks' gestation and admitted to the participating NICUs or postpartum units.
  • Quality Improvement Implementation Survey version 2 (QIIS-II) and semi-structured interview participants: Management staff, nurses, nurse practitioners, physicians, and allied health staff employed in participating NICUs.

Exclusion Criteria

  • Preterm Infants:
  • Major congenital anomalies or chromosomal abnormalities.
  • Primary admission to a surgical NICU: Alberta Children's Hospital or Stollery Children's Hospital.
  • Infants born in or transferred to a NICU outside Alberta.
  • Patients who have imposed confidentiality restrictions on accessing their health records.

Outcomes

Primary Outcomes

Length of Stay

Time Frame: Birth until discharge home or death, whichever came first, assessed until the participant reaches a corrected age of 6 months (6 months after their birth due date).

The duration of hospitalization until final discharge.

Secondary Outcomes

  • Surfactant administration(First 168 hours of age.)
  • Cost to healthcare system per participant(Birth until discharge home or death, whichever came first, assessed until the participant reaches a corrected age of 6 months (6 months after their birth due date).)
  • Number of participants with Hypothermia(Within 1 hour of birth)
  • Duration of respiratory support(Birth until discharge home or death, whichever came first, assessed until the participant reaches a corrected age of 6 months (6 months after their birth due date).)
  • Head circumference in centimeters(At discharge home in survivors, assessed up to a corrected age of 6 months (6 months after their birth due date).)
  • Breastmilk use(Birth until discharge home or death, whichever came first, assessed until the participant reaches a corrected age of 6 months (6 months after their birth due date).)
  • Hospital mortality(Until first discharge home, assessed until the participant reaches a corrected age of 6 months (6 months after their birth due date).)
  • Transfer from Level II to Level III NICU(Until first discharge home, assessed until the participant reaches a corrected age of 6 months (6 months after their birth due date).)
  • Time to regain birth weight(Birth until discharge home or death, whichever came first, assessed until the participant reaches a corrected age of 6 months (6 months after their birth due date).)
  • Number of participants with Hypoglycemia(First 24 hours of age)
  • Length in centimeters(At discharge home in survivors, assessed up to a corrected age of 6 months (6 months after their birth due date).)
  • Number of emergency room visits per participant(Within 30 days after discharge home)
  • Infant mortality before 1 year of corrected age(Before 1 year of corrected age)
  • Age at achieving full enteral feeding(Birth until discharge home or death, whichever came first, assessed until the participant reaches a corrected age of 6 months (6 months after their birth due date).)
  • Weight in grams(At discharge home in survivors, assessed up to a corrected age of 6 months (6 months after their birth due date).)
  • Number of unplanned rehospitalizations per participant(Within 30 days after discharge home)
  • Staff perception of collaborative QI (EPIQ) implementation.(Year 2, 3, and 4 of study)

Study Sites (12)

Loading locations...

Similar Trials